NorthWest Health Prop Real Est Inv Trust (TSE:NWH.UN) Stock Passes Above 200 Day Moving Average - Here's What Happened

Key Points

• NorthWest Health Prop Real Est Inv Trust's shares have surpassed their 200-day moving average, trading at C$5.15 after reaching a high of C$5.18.
• The company has a market capitalization of C$1.28 billion and a high debt-to-equity ratio of 129.42, indicating significant leverage.
• NorthWest Healthcare Properties provides access to a diversified portfolio of healthcare real estate across regions including Australasia, Brazil, Germany, and Canada.

Shares of NorthWest Health Prop Real Est Inv Trust (TSE:NWH.UN - ) passed above its 200-day moving average during trading on Friday . The stock has a 200-day moving average of C$4.90 and traded as high as C$5.18. NorthWest Health Prop Real Est Inv Trust shares last traded at C$5.15, with a volume of 655,638 shares.

NorthWest Health Prop Real Est Inv Trust Stock Up 0.4%

The company has a current ratio of 0.25, a quick ratio of 0.06 and a debt-to-equity ratio of 129.42. The firm has a market capitalization of C$1.28 billion, a P/E ratio of -12.29, a P/E/G ratio of 0.74 and a beta of 1.53. The company has a 50 day simple moving average of C$4.92 and a two-hundred day simple moving average of C$4.90.

NorthWest Health Prop Real Est Inv Trust Company Profile

Northwest Healthcare Properties Real Estate Investment Trust provides investors with access to a portfolio of high-quality healthcare real estate. The company provides investors exposure to a well-diversified portfolio of healthcare real estate located in the greater areas of cities such as Australasia, Brazil, Germany, and Canada of which Australasia derives a majority of revenue to the company.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.